- Duración
- 01/05/2017-30/04/2022
- Coordinador
- Clara Menéndez
- Financiadores
- UNITAID
- Página web
- https://www.tiptopmalaria.org
In sub-Saharan Africa (SSA), over 30 million pregnant women are annually exposed to infection from malaria. Of these, an estimated 10,000 pregnant women and up to 200,000 newborns die from malaria in pregnancy (MiP), primarily due to the infection from Plasmodium falciparum bites. Furthermore, recent data indicate that up to 20% of stillbirths in SSA are attributable to MiP. In the broader framework of the 2030 agenda, the TIPTOP project is well aligned with the overall SDG3 health targets of accelerating maternal and newborn mortality reduction in the Sub Saharan region and reflects well how different stakeholders have a role and responsibility in helping to achieve these ambitious goals: from sub Saharan African countries to donors, international development and research partners.
IThis 5-year project, funded by UNITAID and implemented by Jhpiego (coordinator) and ISGlobal (research partner) in collaboration with the World Health Organization (WHO) and the Medicines for Malaria Venture (MMV), aims to increase intermittent preventive treatment in pregnancy (IPTp) for malaria with sulfadoxine-pyrimethamine (SP)—in addition to the use of insecticide-treated bed nets (ITNs) and effective case management IPTp coverage— and expand antenatal care attendance primarily through Community Health Workers in four Sub Saharan African countries: DRC, Mozambique, Madagascar and Nigeria. A learning-driven approach will be employed throughout the project to guide expansion in a two-phase process and generate sufficient evidence to inform WHO policy recommendations and future actions in each country, in an effort to expand the intervention over the long-term.
In an initial phase 10,000 pregnant women per country are expected to be reached (2 years). Then in the so-called expansion phase (3 years) 30,000 pregnant women per country will be enrolled. This project plans to engage community health workers to increase IPTp delivery and demand, catalyzing and further encouraging scale-up of IPTp in Africa. Additionally, it will expand antenatal care attendance in these four African countries.
ISGlobal is the lead evaluation and research organization and is responsible for implementing a set of studies to generate evidence for global guidance on community IPTp-SP. Specifically, ISGlobal will be responsible for designing and implementing the project’s evaluation plan, as well as designing, analyzing and reporting the operational research studies to assess the cost and acceptability of the intervention and its impact.
Total funding:
- Total Project Funding: $50M
- Total ISGlobal Funding: $10.4 M
More Information:
- Landmark Agreement Signed to Prevent Malaria in Pregnancy (ISGlobal)
- Landmark agreement signed to prevent malaria in pregnancy and reduce life-threatening complications in sub-Saharan Africa (UNITAID)
- Malaria in Pregnancy: Intermittent Preventive Treatment (ISGlobal)
Nuestro equipo
PI
-
Clara Menéndez Research Professor, Directora de la Iniciativa y del Programa de Salud Materna, Infantil y Reproductiva
ISGlobal team
-
Franco Massimo Giovanni Pagnoni Coordinador de Cooperación Técnica
-
Mireia Llach Medical Research Fellow
-
Maria del Pilar Fontserè Serra
-
Susana Méndez Bartolomé
-
Montse Pi Project Assistant
-
Maximo Ramirez Robles
Otros proyectos
Ver proyectos pasadosICARIA
Improving Care through Azithromycin Research for Infants in Africa
MESA
La Alianza Científica para la Erradicación de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicación de la malaria.
Estudio inmunológico de la vacuna RTS,S
Estudio de correlatos de protección frente a la malaria después de la vacunación con RTS,S/AS01E: Una evaluación inmunológica exhaustiva en el ensayo clínico de Fase III, doble ciego, aleatorizado, multicéntrico con un grupo control
Alianza Mozambiqueña para la Eliminación de la Malaria (MALTEM)
Alianza Mozambiqueña para la Eliminación de la Malaria
MiPMon
Pregnant women as a sentinel group for malaria surveillance in an era of changing malaria transmission
Severe malaria and microRNAs
A path towards new diagnostic and prevention tools for severe infectious pathologies
AlphaGal
Exploration of the singularities of the sugar nucleotide metabolism and description of novel glycosylation pathways in the malaria parasite
Epigenetic variation in malaria parasites II
Investigating new aspects of the mechanisms and biological functions of epigenetic variation in malaria parasites
Mechanistic aspects of P. vivax
Mechanistic aspects of anemia and splenomegaly caused by plasmodium vivax, a neglected human parasite
BOHEMIA
Broad One Health Endectocide-based Malaria Intervention in Africa
ASINTMAL
Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults
GenMoz
P. falciparum genomic intelligence in Mozambique
ADAM
Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
ECO
Equidad y Optimización del Acceso al Diagnóstico y Tratamiento de la COVID-19 en Bolivia y Paraguay
Science4Pandemics
Citizens engagement digital platform for collective intelligence in pandemics
HIDDENVIVAX
Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria
Subclinical Infections in Children and Long Term Health Effects
Infection acquisition in early life and health outcomes in childhood - MARATO TV3
Diagnosis and Surveillance of Vector-Borne Viruses and Hemoparasites accross the Human Wildlife Interface in the Amazon Basin
Project Code: AC18/00054
Impacto de las coinfecciones en el balance de respuestas de anticuerpos y linfocitos T helper a antígenos diana de inmunidad natural y vacunal frente a patógenos humanos prominentes
Project Code: PI20/00866
CaDMIA-plus
Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte
METRO
Measuring community prevalence among HIV exposed children in rural Southern Mozambique
MAMAH
Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
Infección por virus Zika en mujeres embarazadas que han viajado a zonas afectadas y evaluación de impacto en salud infantil
MIBio
Identification of Prematurity and Pre-Eclampsia as Causes of Mortality
STREESCO
Strengthening Epidemiological Surveillance in Benin and Burkina Faso for an Effective Response to COVID-19
MA-CoV
Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations
IPERVAC-SL
Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone
RESPIRE
Respiratory syncytial virus (RSV) in African pregnant women and children
VITAL
Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance
SARA (SARS-CoV-2 and Acetylsalicylic acid)
Efficacy of low dose acetylsalicylic acid in preventing adverse maternal and perinatal outcomes in SARS-CoV-2 infected pregnant women
HIV drug resistance (HIVDR)
Description of HIV drug resistance patterns and its association with the risk of HIV mother to child transmission among pregnant women from southern Mozambique